United Therapeutics (UTHR) Change in Inventory (2009 - 2026)
United Therapeutics (UTHR) reported Change in Inventory of $40.1 million for Q1 2026, up 258.04% on a YoY basis from $11.2 million in Q1 2025, and up 143.03% sequentially from $16.5 million in Q4 2025.
United Therapeutics (UTHR) Change in Inventory (2009 - 2026) Analysis & Trends
United Therapeutics (UTHR) has 18 years of Change in Inventory data on file, last reported at $40.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 258.04% year-over-year to $40.1 million; the trailing twelve-month figure through Mar 2026 stood at $81.5 million (up 67.01% YoY), and the FY2025 full-year result was $52.6 million, up 12.15% from the prior year.
- Change in Inventory rose to $40.1 million in Q1 2026, from $16.5 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $40.1 million in Q1 2026 to a low of -$5.7 million in Q1 2022.
- A 5-year average of $9.8 million and a median of $9.3 million in 2024 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 13800.0% in 2022, while the deepest fall reached 359.09% in 2022.
- Tracing UTHR's Change in Inventory over 5 years: stood at $13.9 million in 2022, then slumped by 49.64% to $7.0 million in 2023, then jumped by 65.71% to $11.6 million in 2024, then soared by 42.24% to $16.5 million in 2025, then jumped by 143.03% to $40.1 million in 2026.
- Business Quant data shows UTHR's Change in Inventory at $40.1 million in Q1 2026, $16.5 million in Q4 2025, and $17.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.10 Mn |
| Mar 31, 2026 | 40.10 Mn |
| Dec 31, 2025 | 16.50 Mn |
| Dec 31, 2025 | 16.50 Mn |
| Sep 30, 2025 | 17.50 Mn |
| Sep 30, 2025 | 17.50 Mn |
| Jun 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | 7.40 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | 11.60 Mn |
| Dec 31, 2024 | 11.60 Mn |
| Sep 30, 2024 | 11.30 Mn |
| Sep 30, 2024 | 11.30 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Jun 30, 2024 | 14.70 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Dec 31, 2023 | 7.00 Mn |
| Dec 31, 2023 | 7.00 Mn |